Online CBT for preschool anxiety disorders: A randomised control trial
Online CBT for preschool anxiety disorders: A randomised control trial
复制标题
DOI：
10.1016/j.brat.2014.05.001
复制
发表时间：
2014-07-01
影响因子：
4.1
通讯作者：
March, Sonja
中科院分区：
文献类型：
--
作者：
Donovan, Caroline L.;March, Sonja
本研究的目的是调查一个基于互联网的，治疗师协助，家长为重点，CBT计划与焦虑症的学龄前儿童的疗效。将52名3-6岁儿童随机分为网络治疗组（NET）和候补对照组（WLC）。父母在治疗前、治疗后和6个月随访时完成诊断访谈和在线问卷。治疗后的结果显示，与WLC条件相比，NET中儿童的临床严重程度、焦虑症状和内化行为显著降低，整体功能增加。然而，组间差异不明显，从治疗前到治疗后的百分比的儿童谁失去了他们的主要焦虑诊断或谁失去了所有的焦虑诊断。在治疗后的完整样本中，39.1%的NET儿童与25.9%的WLC儿童没有初步诊断。在6个月随访时，在整体功能方面保持了治疗增益，并在临床严重程度、焦虑症状和内化行为方面进一步改善。到6个月的随访完成样本，70.6%的儿童是免费的初步诊断。研究结果表明，幼儿焦虑的网络干预是可行的，有效的，受到家长的欢迎。澳大利亚临床试验注册号：ACTRN 12612000139875。(C)2014爱思唯尔有限公司版权所有。
The aim of this study was to investigate the efficacy of an internet-based, therapist assisted, parent-focussed, CBT program for preschoolers with anxiety disorders. Fifty-two children aged 3-6 years were randomly allocated into internet treatment (NET) and waitlist control (WLC) groups. Parents completed diagnostic interviews and online questionnaires at pre-treatment, post-treatment and 6-month follow-up. Results at post-treatment showed a significantly greater reduction in clinical severity, anxiety symptoms and internalising behaviour, as well as a greater increase in overall functioning for children in the NET compared to the WLC condition. However, group differences were not evident from pre- to post-treatment on the percentages of children who lost their primary anxiety diagnosis or who lost all anxiety diagnoses. At post-treatment for the completer sample, 39.1% of the NET children compared to 25.9% of the WLC were free of their primary diagnosis. At 6-month follow-up, treatment gains were maintained in the case of overall functioning and further improved upon with respect to clinical severity, anxiety symptoms and internalising behaviour. By 6-month follow-up for the completer sample, 70.6% of children were free of their primary diagnosis. The results suggest that an internet program for preschool anxiety is feasible, efficacious and well received by parents. Australian Clinical Trial Registration Number: ACTRN12612000139875. (C) 2014 Elsevier Ltd. All rights reserved.